Periarticular Injection Cocktail for TKA
For primary total knee arthroplasty, use a periarticular injection containing bupivacaine 0.25-0.5% (100-150 mg), tranexamic acid (dose per institutional protocol), dexamethasone 4-10 mg, and ketorolac 30 mg, with epinephrine 1:300,000 for hemostasis, delivered in a total volume of 60-150 mL. This combination provides effective analgesia while avoiding nalbuphine, which lacks evidence in this specific application.
Rationale and Evidence-Based Composition
Bupivacaine (Local Anesthetic Base)
The local anesthetic forms the foundation of your cocktail. Use 0.25-0.5% bupivacaine at 100-150 mg total dose 1, 2, 3. Recent high-quality evidence demonstrates that periarticular injection alone provides comparable outcomes to combined regional blocks 1. The 2026 trial showed PAI-only patients achieved similar pain control, opioid consumption, and functional recovery as those receiving adductor canal block plus IPACK blocks, suggesting the cocktail itself is highly effective when properly formulated.
Volume matters: Deliver in 60-150 mL total volume to ensure adequate tissue distribution 2, 4, 3. The larger volume facilitates spread throughout the periarticular tissues.
Tranexamic Acid
Include TXA in your cocktail based on institutional protocols. While the FDA label describes systemic dosing at 1,000 mg (100 mg/mL) 5, topical/periarticular application has become standard practice. The 2019 ICAROS guidelines support neuraxial anesthesia techniques that facilitate multimodal approaches 6, and TXA fits within this framework for hemostasis and potentially reduced inflammation.
Dexamethasone
Add dexamethasone 4-10 mg to the mixture 7, 3. The FDA label supports intra-articular dosing of 2-4 mg for large joints like the knee 7, though higher doses up to 10 mg are used in practice. A 2015 randomized trial found that adding methylprednisolone to ropivacaine-morphine-ketorolac showed lower CRP values and greater ROM, though pain scores were similar 3. Dexamethasone provides anti-inflammatory effects that extend beyond simple analgesia.
Ketorolac (Not Nalbuphine)
Replace nalbuphine with ketorolac 30 mg 2, 3. The evidence strongly supports ketorolac as part of periarticular cocktails. The 2015 study demonstrated that ropivacaine + morphine + ketorolac provided significantly stronger analgesic effects than ropivacaine alone, with benefits lasting 12-24 hours postoperatively 3.
Critical point: Nalbuphine lacks specific evidence for periarticular injection in TKA. The 2008 guidelines explicitly state that intra-articular morphine shows "inconsistent analgesic efficacy" 8, and nalbuphine has even less supporting data in this context. Ketorolac's NSAID properties complement the local anesthetic and corticosteroid.
Epinephrine
Add epinephrine 1:300,000 to prolong local anesthetic duration and reduce systemic absorption 4, 3. This is standard practice and improves safety by keeping serum bupivacaine levels well below toxic thresholds.
Injection Technique Considerations
Deliver the injection after implantation of components but before wound closure 2. Some protocols use a two-stage approach: the bulk after implantation plus a smaller incisional injection before closure, which has shown superior efficacy 2.
Target tissues: Inject into posterior capsule, collateral ligaments, periosteum, and subcutaneous tissues systematically. The goal is comprehensive coverage of pain-generating structures.
Safety Profile
This combination maintains serum bupivacaine concentrations well below toxic thresholds (2.5 μg/mL). Studies show peak levels of 0.55-1.2 μg/mL when using 125-150 mg bupivacaine 9, 4. No signs of local anesthetic systemic toxicity have been reported with these doses.
What NOT to Include
- Avoid nalbuphine: No evidence supports its use in periarticular injection for TKA
- Avoid intra-articular morphine alone: The 2008 guidelines explicitly recommend against it due to inconsistent efficacy 8
- Don't routinely add regional blocks: Recent evidence shows PAI alone achieves comparable outcomes to combined ACB + IPACK blocks 1, avoiding motor weakness and urinary retention associated with neuraxial techniques
Common Pitfalls
- Insufficient volume: Using <60 mL limits tissue distribution
- Wrong timing: Injecting too early (before implants) or missing the incisional component
- Omitting epinephrine: Increases systemic absorption and shortens duration
- Adding unproven agents: Stick to evidence-based components
Alternative Consideration
If available and budget permits, liposomal bupivacaine (266 mg) mixed with standard bupivacaine HCl (125 mg) provides extended analgesia up to 72 hours 10, 11. A 2026 systematic review found LB improved early pain control and reduced opioid consumption without increased adverse events 10. However, standard bupivacaine cocktails remain highly effective and more cost-efficient 1.